A Companion Diagnostic for Personalizing Mivacurium at the Point-of-Care
Source abstract
Abstract
Mivacurium chloride is envisioned as the “gold-adjunct” in anesthesia and emergency medicine. People across the world are administered mivacurium in emergency situations as clinicians prefer it among the frequently used neuromuscular blockers thanks to its rapid action and short duration. Mivacurium is promptly degraded and deactivated by plasma cholinesterase enzyme (PChE), however during emergency situations, some individuals were found to be unable to metabolize mivacurium shortly after its injection, resulting in prolonged paralysis and potentially lethal respiratory apnea. The most clinically significant cause of this residual paralysis and apnea is the reduced cholinesterase ability to effectively hydrolyze mivacurium. Hitherto, monitoring of mivacurium enzymatic degradation has been remaining a long-standing challenge for analytical chemists as well as anesthesiologists. Firstly, it undergoes rapid hydrolysis by the PChE-enzyme 8 min post-injection, therefore, frequent sampling all through the first minutes after mivacurium administration is mandatory. Secondly, its isolation from biological specimens is extremely difficult due to its chemical properties which involves both hydrophilic and lipophilic characteristics. These challenges impede the development of a universal protocol to be established for screening of PChE-activity towards mivacurium and which clearly identifies patients susceptible to prolonged paralysis. In this study, we designed a point-of-care (PoC) potentiometric sensor that can perform tracking of mivacurium enzymatic degradation kinetics with high accuracy and rapidly. Real serum samples were utilized for in vitro estimation of the rate of mivacurium metabolism, where values of 227 μ mol l −1 and 62 μ M min −1 were obtained for the characteristic parameters of the enzymatic reaction, K m and V max , respectively. Correlation of the results obtained using the proposed approach and earlier LC-MS/MS study is shown.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Analytical Chemistry and Sensors · Electrochemical sensors and biosensors · Electrochemical Analysis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. U.F. and D. Administration · 2013
2. Strategies for integrating personalized medicine into healthcare practice10.2217/pme-2016-0064 ↗
3. Public health in the precision-medicine era10.1056/NEJMp1506241 ↗
4. FDA perspective on companion diagnostics: an evolving paradigm10.1158/1078-0432.CCR-13-1954 ↗
5. The current and future state of companion diagnostics10.2147/PGPM.S49493 ↗
6. A three-dimensional origami paper-based device for potentiometric biosensing10.1002/anie.201606268 ↗
7. In situ sensing of the neurotransmitter acetylcholine in a dynamic range of 1 nM to 1 mM10.1021/acssensors.8b00950 ↗
8. Tunable optical sensing with PVC-membrane-based ion-selective bipolar electrodes10.1021/acssensors.9b00179 ↗
9. Light-addressable ion sensing for real-time monitoring of extracellular potassium10.1002/anie.201811268 ↗
10. Simplified fabrication for ion-selective optical emulsion sensor with hydrophobic solvatochromic dye transducer: a cautionary tale10.1021/acs.analchem.9b01145 ↗
11. A wearable chemical–electrophysiological hybrid biosensing system for real-time health and fitness monitoring10.1038/ncomms11650 ↗
12. Integrated gold-thiol based potentiometric sensors for in situ dual drug-protein binding studies on naproxen/diphenhydramine salts model10.1149/2.0531714jes ↗
13. Strategy for fabrication of stable tramadol solid-contact ion-selective potentiometric sensor based on polyaniline nanoparticles10.1149/2.0161501jes ↗
14. Construction and optimization of a novel acetylcholine ion-selective electrode and its application for trace level determination of propoxur pesticide10.1149/1945-7111/ab8874 ↗
15. Electrochemical preparation of gold nanoparticles-polypyrrole co-decorated 2D MoS 2 nanocomposite sensor for sensitive detection of glucose10.1149/2.1231902jes ↗
16. Real time selective monitoring of the dissolution behavior of pseudoephedrine sulfate and loratadine in their binary and ternary dosage form by utilization of in-line potentiometric sensor10.1149/2.0741908jes ↗
17. Rational design of all-solid-state ion-selective electrodes and reference electrodes10.1016/j.trac.2015.11.004 ↗
18. All-solid-state potentiometric sensors with a multiwalled carbon nanotube inner transducing layer for anion detection in environmental samples10.1021/acs.analchem.5b01941 ↗
19. Wearable potentiometric sensors based on commercial carbon fibres for monitoring sodium in sweat10.1002/elan.201600070 ↗
20. Electrochemical sensing of carbachol in ophthalmic solutions10.1149/2.0571816jes ↗
21. Fabrication of an electroanalytical sensor for determination of deoxyepinephrine in the presence of uric acid using CuFe 2 O 4 nanoparticle/ionic liquid amplified sensor10.1149/2.1261906jes ↗
22. Perspective—challenges in developing wearable electrochemical sensors for longitudinal health monitoring10.1149/1945-7111/ab67b0 ↗
23. Biosensor for monitoring uric acid in wound and its proximity: a potential wound diagnostic tool10.1149/2.1441910jes ↗
24. Review—textile based chemical and physical sensors for healthcare monitoring10.1149/1945-7111/ab6827 ↗
25. Screen printed ion selective electrodes as a fully integrated PAT tool: application to the analysis and impurity profiling of diatrizoate sodium10.1149/2.1311807jes ↗
26. An electrochemical sensor for determination of vitamin B 2 and B 6 based on AuNPs@PDA-RGO modified glassy carbon electrode10.1149/2.1281910jes ↗
27. Electrochemical biosensors based on nanomodified screen-printed electrodes: recent applications in clinical analysis10.1016/j.trac.2016.01.032 ↗
28. Molloy · 2018
29. The identification of mivacurium and metabolites in biological samples10.1093/jat/29.7.637 ↗
30. Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. Supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins10.1007/s11172-016-1487-8 ↗
31. Unexpected prolonged neuromuscular block after mivacurium: a case report10.1159/000048662 ↗
32. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene10.1097/FPC.0000000000000221 ↗
33. Performance evaluation criteria for preparation and measurement of macro- and microfabricated ion-selective electrodes (IUPAC Technical Report)10.1351/pac200880010085 ↗
34. Determination of atracurium, cisatracurium and mivacurium with their impurities in pharmaceutical preparations by liquid chromatography with charged aerosol detection10.1016/j.chroma.2009.12.025 ↗
35. Determination of mivacurium in plasma by high-performance liquid chromatography10.1016/0378-4347(96)00157-0 ↗
36. ICH guideline Q1A(R2) stability testing of new drug substances and products10.1136/bmj.333.7574.873-a ↗
37. In vitro metabolism of mivacurium chloride and succinylcholine10.1213/00000539-198904000-00005 ↗
38. Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study10.1186/s13613-017-0234-0 ↗
39. 2013